drugset / Trial / NCT04044742

A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee

NCT04044742

Phase 3 Withdrawn Sorrento Therapeutics, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the efficacy and safety of intra-articular injection of resiniferatoxin in patients with moderate to severe knee pain due to osteoarthritis.

Timeline

Start
2020-12
Primary completion
2023-03
Completion
2023-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Resiniferatoxin Other / unclassified 12.5 ug Other